These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6425895)

  • 1. Treatment schedule as a determinant of the development of tolerance to haloperidol.
    Carey RJ; DeVeaugh-Geiss J
    Psychopharmacology (Berl); 1984; 82(3):164-7. PubMed ID: 6425895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerance develops to the haloperidol-induced increase in the efflux of dopamine metabolites from the brains of unanesthetized, freely-moving rats.
    Nielsen JA; Duda NJ; Moore KE
    Life Sci; 1982 Oct; 31(14):1495-1500. PubMed ID: 6183554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitization versus tolerance to the dopamine turnover-elevating effects of haloperidol: the effect of regular/intermittent dosing.
    Csernansky JG; Bellows EP; Barnes DE; Lombrozo L
    Psychopharmacology (Berl); 1990; 101(4):519-24. PubMed ID: 2388975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic haloperidol treatment with low doses may enhance the increase of homovanillic acid in rat brain.
    Chang WH; Jaw SS; Tsay L
    Eur J Pharmacol; 1989 Mar; 162(1):151-6. PubMed ID: 2721561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conditional tolerance to haloperidol-induced catalepsy is not caused by striatal dopamine receptor supersensitivity.
    de Graaf CJ; Korf J
    Psychopharmacology (Berl); 1986; 90(1):54-7. PubMed ID: 3094062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of haloperidol-induced increase in rat striatal or mesolimbic 3,4-dihydroxyphenylacetic acid and homovanillic acid by pretreatment with chronic methamphetamine.
    Toru M; Mataga N; Takashima M; Nishikawa T
    Psychopharmacology (Berl); 1981; 74(4):316-20. PubMed ID: 6794073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ontogeny of tolerance to haloperidol: behavioral and biochemical measures.
    Coyle S; Napier TC; Breese GR
    Brain Res; 1985 Nov; 355(1):27-38. PubMed ID: 4075104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of acute and chronic administration of haloperidol on homovanillic acid levels in discrete dopaminergic areas of rat brain.
    Matsumoto T; Uchimura H; Hirano M; Kim JS; Yokoo H; Shimomura M; Nakahara T; Inoue K; Oomagari K
    Eur J Pharmacol; 1983 Apr; 89(1-2):27-33. PubMed ID: 6861888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haloperidol: effect of long-term treatment on rat striatal dopamine synthesis and turnover.
    Lerner P; Nosé P; Gordon EK; Lovenberg W
    Science; 1977 Jul; 197(4299):181-3. PubMed ID: 17917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of haloperidol decanoate on the dopaminergic system in the rat brain].
    Kashihara K; Fujiwara Y; Harada T; Ogawa T; Sato M; Otsuki S
    Yakubutsu Seishin Kodo; 1986 Sep; 6(3):353-8. PubMed ID: 3811625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute and chronic effects of haloperidol on plasma and brain homovanillic acid in the rat.
    Chang WH; Yeh EK; Hu WH; Tseng YT; Chung MC; Chang HF
    Biol Psychiatry; 1986 Apr; 21(4):374-81. PubMed ID: 3955111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Striatal dopamine metabolism increases during long-term haloperidol administration in rats but shows tolerance in response to acute challenge with raclopride.
    See RE
    Neurosci Lett; 1991 Aug; 129(2):265-8. PubMed ID: 1720879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The enhancement of the hypomotility induced by small doses of haloperidol in the phase of dopaminergic supersensitivity in mice.
    Masuda Y; Murai S; Saito H; Abe E; Fujiwara H; Kohori I; Itoh T
    Neuropharmacology; 1991 Jan; 30(1):35-40. PubMed ID: 2046878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific effect of haloperidol on dopamine turnover in the frontal cortex.
    Laduron P; de Bie K; Leysen J
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Jan; 296(2):183-5. PubMed ID: 834317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeated haloperidol administration changes basal release of striatal dopamine and subsequent response to haloperidol challenge.
    Zhang W; Tilson H; Stachowiak MK; Hong JS
    Brain Res; 1989 Apr; 484(1-2):389-92. PubMed ID: 2713698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tardive dyskinesia: behavioral effects of repeated intracerebroventricular haloperidol injections in rats do not confirm the kindling hypothesis.
    Andreassen OA; Jørgensen HA
    Pharmacol Biochem Behav; 1994 Oct; 49(2):309-12. PubMed ID: 7824543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeated testing of rats markedly enhances the duration of effects induced by haloperidol on treadmill locomotion, catalepsy, and a conditioned avoidance response.
    Hillegaart V; Ahlenius S; Magnusson O; Fowler CJ
    Pharmacol Biochem Behav; 1987 May; 27(1):159-64. PubMed ID: 3615537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of haloperidol decanoate, a long-acting neuroleptic, in behavioral and biochemical tests.
    Oka M; Karasawa T; Ochi Y; Asano K; Terauchi Y; Kadokawa T
    Arch Int Pharmacodyn Ther; 1985 Oct; 277(2):289-302. PubMed ID: 4062440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional homovanillic acid levels and oral movements in rats following chronic haloperidol treatment.
    Kolenik SA; Hoffman FJ; Bowers MB
    Psychopharmacology (Berl); 1989; 98(3):430-1. PubMed ID: 2501819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contingent suppression of tolerance to the "anorexigenic" effect of haloperidol.
    Wolgin DL; Thompson GB
    Behav Neurosci; 1989 Jun; 103(3):673-7. PubMed ID: 2736073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.